The Pennant Group, Inc. provides healthcare services in the United States.
$36.36-9.10%
报价 2026-11-06
市值
$1.27B
EV
$1.73B
PE (TTM)
35.0x
预期 PE (FY2026)
25.9x
52 周区间距高点 -17.4%
$24.60$44.04
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
does not hit growth, cheap, or GARP pool
爆发潜力
2026-11-07未命中✗ 收入线✗ EPS 线
| 财年 | 收入倍数 | EPS | PE |
|---|---|---|---|
| FY+22027-12 | 1.1x | 1.37 → 1.59（1.2x） | 22.9 |
| FY+32028-12 | 1.1x | 1.37 → 1.84（1.3x） | 19.7 |
毛利率 13% · TTM 收入 $1175M · 基数 EPS 1.37（调整后）
研究结论
L2 2026-07-06全文 ↓尚未生成 L3 估值，没有三情景目标价。去生成估值 →
L2 报告格式无法提取要点，请看全文。
历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| PNTGThe Pennant Group, Inc. | $1.27B | -9.1% | +27.3% | 13.3% | 35.0x | 23.3x | 49.5x | |
| SNDASonida Senior Living, Inc. | $1.58B | -3.8% | +116.0% | 27.4% | – | 134.2x | – | 高增长 |
| AMNAMN Healthcare Services, Inc. | $1.4B | -23.7% | +24.0% | 30.6% | 17.4x | 6.4x | 4.1x | Cheap GARP |
| INNVInnovAge Holding Corp. | $1.22B | -1.3% | +11.4% | 17.7% | 165.1x | 30.4x | 17.5x | |
| IARTIntegra LifeSciences Holdings Corporation | $1.04B | -5.0% | +0.8% | 51% | 80.0x | 12.0x | 10.6x | |
| HSTMHealthStream, Inc. | $883.9M | -2.4% | +8.7% | 64.7% | 34.1x | 9.3x | 14.8x | |
| KURAKura Oncology, Inc. | $646.7M | +6.9% | +11.1% | 94.7% | – | – | – | |
| BCAXBicara Therapeutics Inc. Common Stock | $572.4M | +5.6% | – | 0% | – | – | – | |
| CRMDCorMedix Inc. | $414.7M | +1.7% | +3.7% | 82.8% | 3.4x | 2.4x | 2.5x | |
| 同行中位数 | – | – | +11.1% | 40.8% | 34.1x | 10.6x | 10.6x |
研究全文
财务报表
| Metric | 2026-09-30 Q3 2026 | 2026-06-30 Q2 2026 | 2026-03-31 Q1 2026 | 2025-12-31 Q4 2025 | 2025-09-30 Q3 2025 | 2025-06-30 Q2 2025 | 2025-03-31 Q1 2025 | 2024-12-31 Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $302.3M | $298M | $285.4M | $289.3M | $229M | $219.5M | $209.8M | $188.9M |
| Gross Margin | 13.3% | 14.1% | 13.1% | 12.9% | 20.2% | 13.8% | 14% | 13.2% |
| Operating Margin | 5.5% | 5.8% | 6.3% | 6.2% | 4.5% | 5.3% | 6% | 4.9% |
| Net Income | $9.6M | $9.1M | $8.5M | $8.6M | $6.1M | $7.1M | $7.8M | $5.8M |
| Diluted EPS | 0.26 | 0.25 | 0.24 | 0.24 | 0.17 | 0.2 | 0.22 | 0.16 |
| Operating Cash Flow | $25.1M | $21.8M | $-3.4M | $21M | $13.9M | $34.6M | $-21.2M | $20.6M |